GEHC (GE HealthCare Technologies) Cash Payments

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GEHC GE HealthCare Technologies Inc GEHC
72 GF Score
Price $69.91
GF Value $84.05
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is GE HealthCare Technologies Cash Payments?

Cash Payments only applicable to companies reporting Cash Flow from Operations in direct method.

GEHC
72GF Score
GE HealthCare Technologies Inc GEHC
Cash Payments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is GE HealthCare Technologies (GEHC) Overvalued in 2026?

Based on GuruFocus' analysis, GE HealthCare Technologies stock appears to be undervalued. The current stock price of $69.91 is trading 16.8% below its estimated GF Value™ of $84.05. GuruFocus considers GE HealthCare Technologies to be Modestly Undervalued.

Key valuation signals for GEHC:

  • Cash Payments:
  • GF Value™: $84.05 vs. price of $69.91 (16.8% below fair value)
  • GF Score™: 72/100 with 3 warning signs

No single metric tells the full story. See the GEHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


GE HealthCare Technologies Business Description

Address 500 West Monroe Street, Chicago, IL, USA, 60661
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
72GF Score

Get the complete analysis for GEHC

Cash Payments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$69.91
Price
$84.05
GF Value